Search for Clinical Trial Results

Sponsored By

Mucopolysaccharidoses - 25 Studies Found

Status Study
Recruiting Study Name: Hematopoietic Stem Cell Transplantation for Mucopolysaccharidosis
Condition: Mucopolysaccharidosis
Date: 2010-11-08
Interventions:
  • Drug: Conditioning regimen

Completed Study Name: Natural History Studies of Mucopolysaccharidosis III
Condition:
  • Mucopolysaccharidosis Type IIIA
  • Mucopolys
    Date: 2013-11-26
    Interventions:
    • Procedure: Lumbar puncture
    • Device: Magneti
Recruiting Study Name: A Study of JR-141 in Patients With Mucopolysaccharidosis Type II
Condition: Mucopolysaccharidosis II
Date: 2017-04-10
Interventions: Drug: JR-141 IV infusion (lyophilized powder), 0.01-2.0 mg/kg/week
Completed Study Name: Study of rhASB in Patients With Mucopolysaccharidosis VI
Condition: Mucopolysaccharidosis VI
Date: 2005-02-24
Interventions:
  • Drug: N-acetylgalactosamine 4-sulfatase

Recruiting Study Name: Mucopolysaccharidosis I (MPS I) Registry
Condition: Mucopolysaccharidosis I (MPS I)
Date: 2005-09-02
Not yet recruiting Study Name: Mucopolysaccharidosis (MPS) Screening in a High-Risk Population With Previous Surgical Repair or Presence of Inguinal and/or Umbilical Hernia Combined With Pediatric ENT Surgery or Bronchoscopy
Condition: Mucopolysaccharidoses
Date: 2017-01-09
Terminated Study Name: Discovering New Biomarkers For Monitoring Disease Progression in Patients With Mucopolysaccharidosis IVA
Condition: Mucopolysaccharidosis Type IVA
Date: 2012-11-21
Completed Study Name: Diagnosis of Mucopolysaccharidosis Disorders in Patients Presenting With Bilateral Hip Disease
Condition:
  • Mucopolysaccharidosis IV A
  • Mucopolysaccha
    Date: 2012-10-12
    Interventions: Other: Enzyme testing Leukocyte activity measurement of Arylsulfatase B and N acetyl galactosamine 6 sul
Completed Study Name: Immune Tolerance Study With Aldurazyme® (Laronidase)
Condition: Mucopolysaccharidosis I
Date: 2008-08-13
Interventions:
  • Biological: Laronidase 0.058 m
Completed Study Name: An Open-Label Phase 1/2 Study to Assess the Safety, Efficacy and Dose of Study Drug UX003 Recombinant Human Beta-glucuronidase (rhGUS) Enzyme Replacement Therapy in Patients With MPS 7
Condition: Mucopolysaccharidosis Type 7
Date: 2013-05-08
Interventions: Drug: UX003
Next >>>